A prospective phase II study: high-dose pemetrexed as second-line chemotherapy in small-cell lung cancer.

Purpose: To investigate the efficacy and tolerability of high-dose pemetrexed as second-line chemotherapy in small cell lung cancer (SCLC). Patients and methods: Patients with verified SCLC who had ...